Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
EMA-aanbevelingen voor gebruik remdesivir bij COVID-19
apr 2020 | Pneumonie, Virale infecties